Clinical Trial Update: Brain Function in Premenopausal Women Receiving Tamoxifen With or Without Ovarian Function Suppression for Early-Stage Breast Cancer on Clinical Trial IBCSG 24-02 [Phase 3]

View source ↗

Summary

Phase 3 trial evaluating brain function in premenopausal women with early-stage breast cancer treated with tamoxifen with or without ovarian function suppressio…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Breast Cancer

Drugs mentioned

• Tamoxifen (tamoxifen)

Snippet

Sponsor: ETOP IBCSG Partners Foundation | Conditions: Breast Cancer, Fatigue | Phase 3 | Status: COMPLETED | Results posted: 2016-07-25